Puma Biotechnology to Present at B. Riley Securities' 3rd Annual Oncology Conference

Author's Avatar
Jan 12, 2023

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 11:00 a.m. PST/2:00 p.m. EST on January 19 at the virtual B. Riley Securities’ 3rd Annual Oncology Conference. A live webcast of Mr. Auerbach’s presentation will be accessible via registration on the event website at https%3A%2F%2Fbrileyoncology22.sequireevents.com%2F. A replay of the presentation will be available at the same address.